These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17130274)

  • 1. Inflammatory syndrome in patients on hemodialysis.
    Jofré R; Rodriguez-Benitez P; López-Gómez JM; Pérez-Garcia R
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S274-80. PubMed ID: 17130274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutritional therapy to attenuate inflammation in HD patients: fact or fiction?
    Sharma A; Gadepally P
    Nephrol News Issues; 2010 Jan; 24(1):26-9. PubMed ID: 20196499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes and consequences of inflammation on anemia management in hemodialysis patients.
    Chawla LS; Krishnan M
    Hemodial Int; 2009 Apr; 13(2):222-34. PubMed ID: 19432697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition.
    de Mutsert R; Grootendorst DC; Indemans F; Boeschoten EW; Krediet RT; Dekker FW;
    J Ren Nutr; 2009 Mar; 19(2):127-35. PubMed ID: 19218039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation.
    Morena M; Delbosc S; Dupuy AM; Canaud B; Cristol JP
    Hemodial Int; 2005 Jan; 9(1):37-46. PubMed ID: 16191052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
    Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
    Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro- and anti-inflammatory cytokines in chronic pediatric dialysis patients: effect of aspirin.
    Goldstein SL; Leung JC; Silverstein DM
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):979-86. PubMed ID: 17699316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ["Malnutrition-inflammation complex syndrome" in chronic hemodialysis].
    Young P; Lombi F; Finn BC; Forrester M; Campolo-Girard V; Pomeranz V; Iriarte R; Bruetman JE; Trimarchi H
    Medicina (B Aires); 2011; 71(1):66-72. PubMed ID: 21296726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quotidian hemodialysis and inflammation associated with chronic kidney disease.
    Hamlett L; Haragsim L
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):e35-42. PubMed ID: 17603973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Strong connection between malnutrition, inflammation and arteriosclerosis. Improved treatment of renal failure if underlying factors are attacked].
    Efendic E; Lindholm B; Bergström J; Stenvinkel P
    Lakartidningen; 1999 Oct; 96(42):4538-42. PubMed ID: 10575860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of inflammatory factors and cardiac troponin T in hemodialysis patients.
    Falaknazi K; Bagheri N; Taziki O
    Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):219-22. PubMed ID: 19237807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dialysis-related systemic microinflammation is associated with specific genomic patterns.
    Zaza G; Pontrelli P; Pertosa G; Granata S; Rossini M; Porreca S; Staal FJ; Gesualdo L; Grandaliano G; Schena FP
    Nephrol Dial Transplant; 2008 May; 23(5):1673-81. PubMed ID: 18048420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effect of standard heparin versus low molecular weight heparin on oxidative stress and inflammation in hemodialysis patients.
    Poyrazoglu OK; Dogukan A; Yalniz M; Seckin D; Gunal AL
    Ren Fail; 2006; 28(8):723-7. PubMed ID: 17162433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients.
    Carrero JJ; Chmielewski M; Axelsson J; Snaedal S; Heimbürger O; Bárány P; Suliman ME; Lindholm B; Stenvinkel P; Qureshi AR
    Clin Nutr; 2008 Aug; 27(4):557-64. PubMed ID: 18538898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of anti-HCV positivity on markers of malnutrition and inflammation in hemodialysis patients.
    Zumrutdal A; Ozer B; Singan M; Micozkadioglu H; Sezer S; Ozdemir FN; Haberal M
    Ren Fail; 2007; 29(1):85-90. PubMed ID: 17365915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin treatment and diabetes affect myeloperoxidase activity in maintenance hemodialysis patients.
    Stenvinkel P; Rodríguez-Ayala E; Massy ZA; Qureshi AR; Barany P; Fellström B; Heimburger O; Lindholm B; Alvestrand A
    Clin J Am Soc Nephrol; 2006 Mar; 1(2):281-7. PubMed ID: 17699218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
    Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inflammatory markers, nutritional parameters and polyunsaturated fatty acids in hemodialysis patients].
    Perunicić-Peković GB; Pljesa SI; Rasić ZR; Stanković SD; Ilić MN
    Med Pregl; 2007; 60 Suppl 2():43-7. PubMed ID: 18928156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasting glucose levels in predicting 1-year all-cause mortality in patients who do not have diabetes and are on maintenance hemodialysis.
    Lin-Tan DT; Lin JL; Wang LH; Wang LM; Huang LM; Liu L; Huang JY; Huang YL
    J Am Soc Nephrol; 2007 Aug; 18(8):2385-91. PubMed ID: 17599971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic inflammation, oxidative stress and effects of erythropoetin in end-stage renal disease patients].
    Lazarević T; Stojimirović B; Poskurica M; Lazarević M; Mitrović N; Stolić R
    Med Pregl; 2007; 60 Suppl 2():109-13. PubMed ID: 18928173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.